Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
2024 Prescription Drugs and Antibiotics Wholesale Global Market Size & Growth Report with Updated Analysis & Forecasts
... growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with forecasts for 2024 and 2028. The ... Read More
-
2024 Prescription Veterinary Medicines Retail Sales Global Market Size & Growth Report with Updated Analysis & Forecasts
... growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with forecasts for 2024 and 2028. The ... Read More
-
2024 Prescriptions Retail Sales Global Market Size & Growth Report with Updated Analysis & Forecasts
... 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with forecasts for 2024 and 2028. The historical data utilizes in-depth ... Read More
-
2024 Prosthodontic Services Global Market Size & Growth Report with Updated Analysis & Forecasts
... regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with forecasts for 2024 and 2028. The historical data utilizes in-depth survey results ... Read More
-
Global Hypoparathyroidism Market 2024-2028
... analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, ... Read More
-
Global Human Chorionic Gonadotropin (HCG) Market 2024-2028
... the human chorionic gonadotropin (HCG) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
2024-2028 Global Opiates Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Global Methadone Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
Immunosuppressants
... of 13.8% over the analysis period 2023-2030. Calcineurin Inhibitors, one of the segments analyzed in the report, is expected to record a 15.8% CAGR and reach US$38.5 Billion by the end of the analysis period. ... Read More
-
Spinal Cord Trauma Treatment
... reach US$3.9 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Partial Spinal Cord Injuries Treatment, one of the segments analyzed in the report, is expected to record a 3.7% ... Read More
-
Systemic Lupus Erythematosus (Sle) Drugs
... is expected to reach US$362.4 Million by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. The U.S. Market is Estimated at US$63.3 Million While China is Forecast to Grow at 6.0% ... Read More
-
MRSA Drugs
... at a CAGR of 4.4% over the analysis period 2023-2030. Glycopeptides & Lipoglycopeptides, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$726.5 Million by the end ... Read More
-
Opioids
... of 2.3% over the analysis period 2023-2030. Extended-Release / Long-Acting Opioids, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$18.7 Billion by the end of the ... Read More
-
Anxiolytics
... 4.6% over the analysis period 2023-2030. The U.S. Market is Estimated at US$250.6 Million While China is Forecast to Grow at 7.1% CAGR The Anxiolytics market in the U.S. is estimated at US$250.6 Million in ... Read More
-
Antineoplastic Agents
... at a CAGR of 7.1% over the analysis period 2023-2030. Chemotherapeutic Agents Application, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$137.9 Billion by the end ... Read More
-
Eye Allergy Therapeutics
... by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Antihistamines, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.2 Billion by the ... Read More
-
Swine Health
... at a CAGR of 5.8% over the analysis period 2023-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Substance Abuse Treatment
... by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Nicotine Addiction Treatment, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$9.4 Billion ... Read More
-
Global Malignant Pleural Mesothelioma Market (2024 Edition): Analysis By Drug Type (Pemetrexed and Combination, Cisplatin, Carboplatin, Gemcitabine, Vinorelbine, Other Drug Types), By Route of Administration, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)
... Forecast (2020-2030) Executive Summary Azoth Analytics has released a research report titled “Global Malignant Pleural Mesothelioma Market (2024 Edition)” which provides a Pemetrexed and Combination analysis of the Global Malignant Pleural Mesothelioma industry in terms ... Read More
-
Non-Hodgkin Lymphoma Therapeutics
... by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$10.1 Billion by the ... Read More
-
Clostridium Difficile Treatment
... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Metronidazole, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$915.6 Million by the ... Read More
-
Nocturia Drugs
... at a CAGR of 6.1% over the analysis period 2023-2030. Low Nocturnal Bladder Capacity Indication, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.0 Billion by ... Read More
-
Statins
... of 1.8% over the analysis period 2023-2030. Synthetic Statins, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$12.2 Billion by the end of the analysis period. ... Read More
-
Prescription Drugs Market
... USD 2,151.63 billion by 2032, exhibiting a CAGR of 7.1% during the forecast period of 2024-2032. The COVID-19 pandemic disrupted supply chains and delayed scientific trials in the Prescription Drugs Market, main to shortages of ... Read More
-
Cold Pain Therapy
... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. OTC Products, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.9 Billion by ... Read More
Research Assistance
